Evidence map›Paper›PMID 42045439›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2026

A novel mouse model of adenine-supplemented high-fat diet induced cardiovascular-kidney-metabolic syndrome.

Hiroe Ono, Yoichiro Otaki, Tetsu Watanabe, Ryuhei Yamaguchi, Tomohiro Takehara, Shingo Tachibana, Jun Goto, Takanori Arimoto, Haruki Ochi, Masafumi Watanabe

Abstract read
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hiroe OnoDepartment of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.
Yoichiro OtakiDepartment of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan. y-otaki@med.id.yamagata-u.ac.jp.
Tetsu WatanabeDepartment of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.
Ryuhei YamaguchiDepartment of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.
Tomohiro TakeharaDepartment of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.
Shingo TachibanaDepartment of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.
Jun GotoDepartment of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.
Takanori ArimotoDepartment of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.
Haruki OchiDepartment of Biology, Graduate School of Science and Faculty of Science, Kobe University, Hyogo, Japan.
Masafumi WatanabeDepartment of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular-kidney-metabolic (CKM) syndrome, a recently proposed concept focusing on the interrelationship among cardiovascular system, chronic kidney disease, and metabolic risk factors, is associated with high morbidity and mortality. The mechanism of CKM syndrome has not yet been fully examined due to the lack of an animal model. Here, we investigated whether an adenine-supplemented high-fat diet (AHFD) can induce CKM syndrome in mice. We fed normal chow diet (NCD), adenine-supplemented diet (AD), high-fat diet (HFD), and 0.15% AHFD to 129×1/Sv mice for 16 weeks and 0.2%AHFD to 129×1/Sv for 6 weeks. Also, C57BL/6 N mice were fed with 0.15%AHFD for 16 weeks. Metabolic parameters, blood pressure, organ weights, histology, and RNA sequencing were analyzed. The 0.15%AHFD group exhibited hypercholesterolemia, elevated blood pressure, kidney atrophy with fibrosis, and cardiac hypertrophy with interstitial fibrosis. Both kidney and cardiac RNA sequencing in the 0.15%AHFD group revealed upregulation of inflammatory and immune-related gene sets, whereas genes involved in cardiac contraction were downregulated. In contrast, 0.2%AHFD induced body weight loss, severe kidney dysfunction, and cardiac atrophy without functional impairment in 129×1/Sv mice. Of note, the C57BL/6 N mice exhibited metabolic abnormality and cardiac hypertrophy with diastolic dysfunction after 0.15%AHFD feeding despite mild renal dysfunction. We report a novel mouse model of CKM syndrome with dietary intervention, which exhibits fibrosis and myocardial hypertrophy in the heart. This model could be a valuable tool for analyzing the mechanism of CKM syndrome and assessing therapeutic options.

Indexed as

AdenineCardio-Renal SyndromeDiet, High-FatMetabolic SyndromeAnimalsBlood PressureDisease Models, AnimalKidneyMaleMiceMice, Inbred C57BLMyocardiumAdenineCardiac hypertrophyCKM syndromeImplemental hypertensionKidney atrophy

Identifiers

PMID42045439
PMCPMC13333507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.